La Chaux-de-Fonds, Switzerland

Laure Cahuzac

This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignee: Ichnos Sciences Sa. Active years: 2024-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Laure Cahuzac: Innovator in Viral Contamination Inactivation

Introduction

Laure Cahuzac is a prominent inventor based in La Chaux-de-Fonds, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of methods for inactivating viral contaminants. With a total of 2 patents to her name, her work is crucial in ensuring the safety and efficacy of antibody-containing solutions.

Latest Patents

Cahuzac's latest patents focus on innovative methods for preparing antibody-containing solutions that are free from viral contaminants. The first patent describes a method that involves subjecting the antibody-containing solution to a mix of solvent and detergent or to high pH. This process is essential for eliminating viral contaminants that may arise from cultured cells. The second patent reiterates this method, emphasizing its importance in maintaining the integrity of antibody solutions.

Career Highlights

Laure Cahuzac is currently associated with Ichnos Sciences SA, where she continues to advance her research in viral contamination inactivation. Her expertise in this area has positioned her as a valuable asset to her company and the broader scientific community.

Collaborations

Cahuzac collaborates with talented professionals such as Filipa Abrantes and Sonia Letestu. These collaborations enhance her research efforts and contribute to the innovative environment at Ichnos Sciences SA.

Conclusion

Laure Cahuzac is a dedicated inventor whose work in viral contamination inactivation is paving the way for safer biotechnological applications. Her contributions are vital for the advancement of antibody solutions, ensuring they are free from harmful contaminants.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…